ARF4P2

Across TCGA pan-cancer cohorts, ARF4P2 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated ARF4P2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ARF4P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ARF4P2 expression acts as an unfavorable survival marker, although some lineages such as BLCA and CHOL show a favorable association.

BLCA, COAD, and LIHC are the cancer types where ARF4P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Quartile	II,III,IV	0.696	0.510	.002	111	view →
COAD	OS	Median	All	0.490	0.772	<.001	85	view →
LIHC	DFS	Tertile	All	0.346	0.481	<.001	82	view →
UVM	DFS	Quartile	II,III,IV	0.244	0.743	<.001	45	view →
THCA	OS	Quartile	All	0.949	0.994	.002	35	view →
BRCA	DFS	Tertile	All	0.868	0.935	.001	27	view →
CHOL	OS	Median	All	0.876	0.164	<.001	24	view →
KIRC	OS	Quartile	All	0.552	0.677	.023	20	view →
LAML	DFS	Median	All	0.547	0.370	.013	20	view →
MESO	DFS	Quartile	All	0.270	0.456	.019	14	view →
LUAD	DFS	Quartile	IV	0.135	0.776	.001	14	view →
PRAD	DFS	Quartile	All	0.889	0.951	.016	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

ARF4P2–BLCA (OS)

Open the BLCA breakdown →